Shanghai Henlius Biotech, Inc. (HKG:2696)
Hong Kong · Delayed Price · Currency is HKD 64.20
-3.00 (-4.46%)
Sep 10, 2026, 11:45 AM HKT
Shanghai Henlius Biotech Market Cap
Shanghai Henlius Biotech has a market cap or net worth of 36.52 billion as of September 9, 2026. Its market cap has decreased by -24.24% in one year.
Market Cap
36.52B
Enterprise Value
39.98B
Revenue
8.58B
Ranking
n/a
PE Ratio
36.85
Stock Price
64.20
ChartMarket Cap Chart
Since September 25, 2019, Shanghai Henlius Biotech's market cap has increased from 26.66B to 36.52B, an increase of 37.00%. That is a compound annual growth rate of 4.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 36.52B | 17.79% |
| Dec 31, 2025 | 31.01B | 140.72% |
| Dec 31, 2024 | 12.88B | 70.50% |
| Dec 29, 2023 | 7.55B | 8.59% |
| Dec 30, 2022 | 6.96B | -41.95% |
| Dec 31, 2021 | 11.98B | -53.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akeso | 88.43B |
| Genscript Biotech | 67.79B |
| RemeGen | 67.07B |
| Biocytogen Pharmaceuticals (Beijing) | 53.78B |
| 3SBio | 39.98B |
| Shanghai Junshi Biosciences | 34.69B |
| InnoCare Pharma | 30.80B |
| Keymed Biosciences | 23.49B |